Skip to main content


Clinical trials

02-05-2018 | Granulomatosis with polyangiitis | Article

Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: A single-centre cohort study on 114 patients

Puéchal X et al. Rheumatology (Oxford) 2018: key117. doi: 10.1093/rheumatology/key117

15-05-2017 | Vasculitis | Article

The value of ultrasound in diagnosing extracranial large-vessel vasculitis compared to FDG-PET/CT: A retrospective study

In this study, the authors found Doppler sonography to be a potent method in diagnosing extracranial large-vessel vasculitis, detecting 4 out of 5 cases in the study cohort.

Löffler C, Hoffend J, Benck U, Krämer BK, Bergner R. Clin Rheumatol 2017;36:2079–2086. doi:10.1007/s10067-017-3669-7

12-04-2017 | Quality of life | Article

Quality of life of patients treated for giant cell arteritis: a case-control study

Jobard et al postulated that giant cell arteritis (GCA) patients taking high dose corticosteroids had no significant impairment of quality of life (QOL) compared with controls in their study. GCA complications did not seem to have any major impact on QOL.

Clin Rheumatol 2017; advance online publication; doi:10.1007/s10067-017-3619-4

22-01-2017 | Vasculitis | Article

Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis

The results of this study suggest that use of low-dose rituximab for repeated treatment of relapsing mixed cryoglobulinemia vasculitis is safe, efficacious, and cost-effective for long-term management.

Colantuono S et al. Clin Rheumatol 2017;36:617–623. doi:10.1007/s10067-017-3552-6

Image Credits